Background:
The prognosis of acute rheumatic fever (ARF) is closely tied to the severity of valvular regurgitation. Identifying high-risk children is crucial for optimizing treatment and surgical decisions. This study evaluates clinical outcomes in children with ARF in a high-endemic region of Brazil.
Methods:
A retrospective analysis was conducted on 151 children treated for ARF at a pediatric hospital in Feira de Santana, Bahia, Brazil, between August 2010 and October 2023. The primary outcome was a composite measure of cardiac surgery or death.
Results:
The median age was 9 years (IQR: 7–12), with 46% being female. Carditis, primarily mitral valve involvement, was the most common manifestation (76%), followed by arthritis (52%), chorea (33%), and fever (56%). Over a median follow-up of 17.5 months (IQR: 5.0–51.5), 18 patients underwent cardiac surgery, and 2 died (13% adverse outcome rate). Multivariate analysis identified the absence of fever (OR 0.28, 95% CI: 0.10–0.78, P = 0.012), elevated erythrocyte sedimentation rate (ESR) (OR 1.02, 95% CI: 1.02–1.04, P = 0.006), and low hematocrit (OR 0.91, 95% CI: 0.83–0.99, P = 0.021) as predictors of adverse outcomes (C-statistic: 0.822). Adding ESR improved the model’s predictive performance (NRI: 0.79, P = 0.005; IDI: 0.11, P = 0.032).
Conclusions:
In ARF, the absence of fever, elevated ESR, and low hematocrit were linked to adverse outcomes. ESR, a simple and cost-effective marker, may enhance risk stratification in resource-limited settings.